openPR Logo
Press release

Cephalosporin Market Predicted to Show Remarkable Growth Till 2023 | Allergan, GlaxoSmithKline, Lupin & Pfizer

03-13-2019 08:37 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Cephalosporin Market Predicted to Show Remarkable Growth Till

Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. The major factors contributing to the growth of the market include increase in incidence of population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea.

In addition, an increase in R&D activities to develop highly efficient & safe drugs and the upsurge in the use of combination therapies further boost market growth. However, side effects associated with cephalosporin and development of drug-resistant bacterial strains restrain the market growth.

Request Sample Available @ https://www.alliedmarketresearch.com/request-sample/3510?utm_source=openpr&utm_medium=ss

According to Allied Market Research, the global cephalosporin market was valued at $3,136 million in 2016 and is projected to reach $4,980 million by 2023, growing at a CAGR of 6.8%.

KEY FINDINGS OF THE STUDY

• Fifth-generation cephalosporin is projected to grow at a CAGR of 15.6% during the forecast period.
• Branded cephalosporin segment is expected to register the highest CAGR of 14.4% during the analysis period.
• Injectable cephalosporin is accounted for more than two-fifths share of the global cephalosporin market in 2016.
• France and Germany collectively contributed for around one-third share of the European cephalosporin market in 2016.
• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific cephalosporin market in 2016.

Major Players:

• Allergan Plc
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Lupin Limited
• Merck & Co.Inc.
• Pfizer Inc.

For Enquiry Click @ https://www.alliedmarketresearch.com/purchase-enquiry/3510?utm_source=openpr&utm_medium=ss

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cephalosporin Market Predicted to Show Remarkable Growth Till 2023 | Allergan, GlaxoSmithKline, Lupin & Pfizer here

News-ID: 1650649 • Views: 257

More Releases from Allied Market Research

LiDAR Market 2020-2027: Emerging Trends, Market Share, Top Impacting Factors and …
Allied Market Research published an exclusive report, titled, “LiDAR Market By Type (Terrestrial, Aerial, Mobile, and Short Range), Component (LASER, Inertial Navigation System, Camera, GPS GNSS Receiver, and MEMS), Application (Corridor Mapping, Seismology, Exploration & Detection, and Others), and End User (Defense & Aerospace, Civil Engineering, Archaeology, Forestry and Agriculture, Mining, and Transportation): Global Opportunity Analysis and Industry Forecast, 2020-2027”. The LiDAR market report offers an in-depth analysis of every crucial
Hybrid-Electric Vehicle Insulation Market Technological Innovation, Trends & Top …
Hybrid electric vehicle insulation is used to shield the vehicle from heating, sound & vibrations, and provide a convenient drive to the passengers. Insulators help in controlling the in-vehicle temperature to obtain a comfortable cabin climate. Overheating in hybrid electric vehicles could majorly impact the battery pack and may lead to degradation of the engine performance. Furthermore, the noise & vibrations develop an adverse ambience inside the vehicle. However, vehicle
Passenger Car Adhesives Market Analysis, Key Players, Challenges, Segmentation …
Adhesives are the most versatile bonding components used by automakers to make cars lighter and tougher. It can be found naturally or can be synthetically produced. But the adhesives that are currently utilized in the automotive industry are mostly synthetic in nature, which are used to bind metals, composites, plastic, and other materials. Adhesives are increasingly being used in the automotive industry for binding numerous vehicle components, such as in
Early Toxicity Testing Market Industry Analysis and Forecast (2020-2025) – by …
The global Early Toxicity Testing Market was pegged at $614 million in 2015 and is projected to reach $1,012 million by 2022, registering a CAGR of 7.3% during the period 2016–2022. The report analyzes the leading market players including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Merck & Co., Inc., Becton, Danaher Corporation, The Jackson Laboratory, Bio-Rad Laboratories, Inc., Quest Diagnostics Incorporation, Charles River Laboratories International Incorporation, Dickinson And Company, and

All 5 Releases


More Releases for Cephalosporin

Cephalosporin Market Expert Reviews & Analysis Along With Study Report 2023
Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. The major factors contributing to the growth of the market include increase in incidence of population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea. In addition, increase in R&D activities to develop highly efficient & safe drugs and upsurge in use of combination therapies further boost the market growth. However, side effects associated with cephalosporin
Business Opportunities in Cephalosporin Market by 2023
Cephalosporin market was valued at $3,136 million in 2016, and is projected to reach $4,980 million by 2023, growing at a CAGR of 6.8% from 2017 to 2023. The third-generation cephalosporin segment held around one-third share of the total market in 2016. Get sample copy of this report:https://www.alliedmarketresearch.com/request-sample/3510 The introduction of combination drugs such as multiple antibacterials or antibacterials combined with an inhibitor drives the market growth. The use of combination drugs
Cephalosporin Market Strengths, Weaknesses; Key Players Analysis By QYResearchRe …
Qyresearchreports include new market research report “Global Cephalosporin Market Professional Survey Report 2018” to its huge collection of research reports. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Union Chempharma NCPC Qilu Antibiotics Lupin Pharmaceuticals Hospira Dhanuka Laboratories Fukang Dongying Pharmaceutical Alkem SALUBRIS LIVZON Hetero Drugs CSPC TEVA Download Free exclusive Sample of this report: https://www.qyresearchreports.com/sample/sample.php?rep_id=1548552&type=S The report on the global market for Cephalosporin has been prepared after conducting a fructuous analysis of several industries
Global Cephalosporin Market Specifications, Analysis Forecast 2017 to 2022
Worldwide Market Reports added Latest Research Report titled "Global Cephalosporin Market Professional Survey Report 2018" to its Large Report database. This report studies Cephalosporin in Global Market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share
Global Cephalosporin Drugs Market Professional Survey Report 2017 - 2022
This report studies Cephalosporin Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. Browse complete report at https://www.researchtrades.com/report/global-cephalosporin-drugs-market-professional-survey-report-2017/1217044 This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Allergan Astellas Bristol-Myers Squibb GSK Merck Pfizer Sandoz Orchid Company Lupin TEVA HPGC Aurobindo LKPC Alkem CSPC Taj Pharma DHANUKA LABORATORIES CordenPharma SRS Pharmaceuticals Ankur Drugs and Pharma Request for sample
Cephalosporin Market Growing $1,99,754 million by 2023
Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. It resembles penicillin and hence is used as an alternative for patients who are allergic to penicillin. It is used in the treatment of a variety of clinical conditions, including pneumonia, skin infections, strep throat, staph infections, tonsillitis, bronchitis, otitis media, and gonorrhea. The global cephalosporin market is estimated to reach $1,99,754 million by